Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aura Biosciences (AURA) Cash from Investing Activities (2020 - 2026)

Aura Biosciences filings provide 7 years of Cash from Investing Activities readings, the most recent being $54.9 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 84.14% to $54.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $60.7 million through Mar 2026, down 32.0% year-over-year, with the annual reading at $35.6 million for FY2025, 48.28% down from the prior year.
  • Cash from Investing Activities hit $54.9 million in Q1 2026 for Aura Biosciences, up from $29.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $54.9 million in Q1 2026 and bottomed at -$90.1 million in Q4 2023.
  • Average Cash from Investing Activities over 5 years is -$1.3 million, with a median of $17.9 million recorded in 2022.
  • Peak annual rise in Cash from Investing Activities hit 3231.94% in 2022, while the deepest fall reached 35812.68% in 2022.
  • Aura Biosciences' Cash from Investing Activities stood at -$16.9 million in 2022, then plummeted by 434.01% to -$90.1 million in 2023, then skyrocketed by 132.95% to $29.7 million in 2024, then grew by 0.43% to $29.8 million in 2025, then skyrocketed by 84.07% to $54.9 million in 2026.
  • Per Business Quant, the three most recent readings for AURA's Cash from Investing Activities are $54.9 million (Q1 2026), $29.8 million (Q4 2025), and -$44.0 million (Q3 2025).